To Company Name/SchemeACN/ARSN1. Details of substantial holder (1)NameACN/ARSN (if applicable)-10/09/2026The previous notice was given to the company on21/08/2026The previous notice was dated19/08/20262. Previous and present voting power*The % substantial is based on the shares on issue of...
Change in substantial holding
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from OncoSil Medical
- Change in substantial shareholding for OSL
- Notice Under Section 708A
- Application for quotation of securities - OSL
- Australian Manufacturing Facility Achieves ISO 13485
- 100th Patient Treated with OncoSil device in Spain
Later from OncoSil Medical
- Notice under ASX Listing Rule 3.10A
- Notice of AGM date
- OncoSil Clinical Data to be Presented at EANM 2026
- PALACROS Officially Launched in Amsterdam
- Notice of Annual General Meeting/Proxy Form
